Impact of Aromatherapy on the Delirium of Patients in Intensive Care Unit (NCT04529395) | Clinical Trial Compass
CompletedNot Applicable
Impact of Aromatherapy on the Delirium of Patients in Intensive Care Unit
France161 participantsStarted 2020-09-18
Plain-language summary
The primary objective of this monocenter randomized controlled trial is to assess the efficacy of aromatherapy to prevent delirium in patients hospitalized in an intensive care unit.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years old
* Patient hospitalized in an intensive care unit for an expected duration of at least 24 hours
* Patient requiring mechanical ventilation with initial therapeutic sedation adapted secondarily for comfort sedation, defined by a RASS score target between -2 and 0
* Patient affiliated to/beneficiary of a social security scheme
Exclusion Criteria:
* Allergy to essential and/or vegetable oils
* Palliative sedation
* Foot skin injury contraindicating the application of an oil
* Moribund patient or expected death
* History of dementia
* Participation to a RIPH-1 study
* Pregnant or breastfeeding woman
* Patient under legal protection
* Patient deprived of liberty by judicial or administrative decision
What they're measuring
1
Occurrence of delirium
Timeframe: Up to 15 days after randomization
Trial details
NCT IDNCT04529395
SponsorGroupe Hospitalier de la Region de Mulhouse et Sud Alsace